Serial Number:
77934319
Mark:
KRONEXTA
Status:
Cancelled-Section 8
Status Date:
10-27-2017
Filing Date:
Registration Number:
3933582
Registration Date:
03-22-2011
Pharmaceutical preparations used for the treatment of cancer, pharmaceutical preparations administered as a radiosensitizer and used for the treatment of cancer, pharmaceutical preparations used for the treatment of urological diseases, pharmaceutical preparations used for the treatment of hormonal disorders, peptides-containing pharmaceutical preparations used for hormonal and tumors treatments, pharmaceutical preparations used for the treatment of endocrine diseases, pharmaceutical preparations used for the treatment of carcinoid tumors, pharmaceutical preparations used for the treatment of age-related diseases, pharmaceutical preparation used for the treatment of endometriosis, pharmaceutical preparations used for the treatment of uterine myoma, pharmaceutical preparations used for the treatment of non-malignant tumors, pharmaceutical preparation used for the treatment for begnin prostatic hyperplasia BPH, pharmaceutical preparations used as a tubulin inhibitor, pharmaceutical preparations based on LHRH antagonists platform, pharmaceutical preparations based on angiogenesis inhibitors platform, pharmaceutical preparations used to induce apoptosis
Mark Description:
N/A
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
07-13-2010
Owner:
Mark Drawing Status:
Standart Character Mark
Abandon Date:
N/A
Business Name:
OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L
Correspondent Name:
